Carbonyl reductase Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Carbonyl Reductase monoclonal antibodies for investigating carbonyl reductase in various biological processes. Carbonyl reductase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carbonyl reductase is an essential enzyme that reduces carbonyl compounds to their corresponding alcohols, playing a vital role in drug metabolism and the detoxification of harmful substances. The enzyme significantly influences cellular redox states and has been associated with various diseases, including cancer and metabolic disorders. Understanding carbonyl reductase function is crucial for developing therapeutic strategies and advancing knowledge of metabolic pathways. Researchers can utilize specific conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), to optimize experimental protocols. Advanced research techniques and methodologies enable precise detection and characterization of carbonyl reductase in diverse biological samples. Current studies focus on exploring carbonyl reductase's role in cellular metabolism and disease progression. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling researchers to uncover new insights into carbonyl reductase biology and its therapeutic potential.